| Mar 5 2025 |
This Week in 340B: February 25 – March 3, 2025 |
McDermott Will & Emery |
| Mar 5 2025 |
How Alcohol Exporters Can Use FDII and IC-DISC to Maximize Tax Savings |
McDermott Will & Emery |
| Mar 5 2025 |
New State Legislative Efforts to Regulate Color Additives in Food |
Keller and Heckman LLP |
| Mar 5 2025 |
Meat Industry Pushes Back on Cultivated Meat Bans |
Keller and Heckman LLP |
| Mar 5 2025 |
Raw Milk: State Legislative Updates and Challenges |
Keller and Heckman LLP |
| Mar 5 2025 |
Cultivated Meat: Legislative Challenges from Georgia and South Dakota |
Keller and Heckman LLP |
| Mar 4 2025 |
Attention North Carolina Retailers: Time to Renew Your ABC Permits! |
Ward and Smith, P.A. |
| Mar 4 2025 |
Pest Practices: EPA Uses FIFRA EPA to Adopt Additional Operational and Workplace Controls on Ethylene Oxide |
K&L Gates LLP |
| Mar 4 2025 |
No Funny Business: The Supreme Court Should Get Sirois |
Bradley Arant Boult Cummings LLP |
| Mar 3 2025 |
Alabama Legislature Weighs Substantial Cannabis Reforms: Let’s All Take a Deep Breath |
Bradley Arant Boult Cummings LLP |
| Mar 2 2025 |
Connecticut Bill Addresses “Shrinkflation” |
Keller and Heckman LLP |
| Feb 28 2025 |
APHIS Will Begin Accepting Petitions for Nonregulated Status on March 3, 2025 |
Bergeson & Campbell, P.C. |
| Feb 28 2025 |
McDermott+ Check-Up: February 28, 2025 |
McDermott Will & Emery |
| Feb 27 2025 |
Florida Appellate Court Rules Hookah Products are Taxable OTP |
Jones Walker LLP |
| Feb 27 2025 |
A Regulatory Haze of Uncertainty Continues as the Clock Ticks Toward Phase One of FDA’s LDT Final Rule |
Epstein Becker & Green, P.C. |
| Feb 27 2025 |
TSCA Developments — A Conversation with Richard E. Engler, Ph.D. [Podcast] |
Bergeson & Campbell, P.C. |
| Feb 27 2025 |
Florida Court Rules That the Florida Constitution Requires Employers to Accommodate Off-Duty Medical Marijuana Use |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 27 2025 |
This Week in 340B: February 18 – 24, 2025 |
McDermott Will & Emery |
| Feb 26 2025 |
Guiding Your Company Through Trump’s New Latin America Enforcement Policy |
Bracewell LLP |
| Feb 26 2025 |
Backwards Down the Number Line: Assessing the State of Alabama’s Medical Cannabis Program Four Years After Its Enactment |
Bradley Arant Boult Cummings LLP |
| Feb 26 2025 |
FTC COPPA Updates Provide New Protections for Children |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 26 2025 |
Lawsuit Alleges FDA Has Unduly Delayed Response to PFAS Petition |
Keller and Heckman LLP |
| Feb 26 2025 |
FDA Delays Effective Date for ‘Healthy’ Rule |
Keller and Heckman LLP |
| Feb 25 2025 |
GLP-1 Receptor Agonists: New Frontiers and Challenges |
Foley & Lardner LLP |
| Feb 25 2025 |
Food & Chemicals Unpacked: Making-up for Lost Time: FDA’s Increased Oversight of Cosmetics [Podcast] |
Keller and Heckman LLP |
| Feb 25 2025 |
FDA Bans Red No. 3: What Companies Need to Know |
O'Toole Scrivo, LLC |
| Feb 25 2025 |
GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List |
Foley & Lardner LLP |
| Feb 25 2025 |
A Deepened Divide: Appellate Court Joins False Claims Act Circuit Split in Favor of Health Care Defendants |
Polsinelli PC |
| Feb 25 2025 |
The Story of the Ghost: How a “Loophole” Created a Behemoth of Intoxicating Cannabis Products and What (If Anything) Congress Intends to Do About It |
Bradley Arant Boult Cummings LLP |
| Feb 24 2025 |
Opioids and Common Law Liability for Indirect Economic Harm |
Pierce Atwood LLP |
| Feb 24 2025 |
PFAS Lawsuit Against Industrial Users of PFAS Highlights Risks |
CMBG3 Law |
| Feb 23 2025 |
Multiple States Propose Bans on Food Additives and “Ultra-Processed Foods” |
Keller and Heckman LLP |
| Feb 21 2025 |
FDA Continues Push to Improve Food Labeling Practices in the United States |
Mintz |
| Feb 21 2025 |
McDermott+ Check-Up: February 21, 2025 |
McDermott Will & Emery |
| Feb 21 2025 |
Navigating the EPR Laws: What Alcohol Beverage Producers Need to Know |
McDermott Will & Emery |
